Pitavastatin CAS:147511-69-1 Mea Hana Mea Hoʻolako

He mea hoʻopaʻa ʻo Pitavastatin i ka HMG-CoA reductase e hoʻoulu ai i ka hana mua o ka synthesis cholesterol. ʻIke ʻia ia he pauka ʻala ʻole a keʻokeʻo a melemele māmā. Loaʻa nā hopena ma ka hoʻemi ʻana i ka pae o kekahi mau mea momona e like me ka cholesterol i loko o ke kino. No laila, ua hōʻike nui ʻia no ka mālama ʻana i ka hypercholesterolaemia a no ka pale ʻana i nā maʻi cardiovascular. ʻAʻole hiki iā ia ke hoʻohaʻahaʻa wale i ka cholesterol kiʻekiʻe a me ka triglyceride i kekahi mau maʻi, akā hiki nō hoʻi ke hoʻonui i ka nui o ka lipoprotein density kiʻekiʻe (HDL), nā pae cholesterol "maikaʻi". Pono e lawelawe pū ʻia me kahi ʻai kūpono.

Kauoha a Noi paha i ka ʻŌlelo Kuhi

Nā kikoʻī huahana

Nā Lepili Huahana

Hoʻohana a me ka hopena

He lāʻau anti hyperlipidemic ʻo Pivastatin. ʻAʻole wale ia he lāʻau hoʻohaʻahaʻa lipid hou, kūpono, palekana, a i hana ʻia me nā kemika statin me ke kumukūʻai kiʻekiʻe loa, akā he mea hoʻopaʻa ikaika hoʻi o ka 3-hydroxy-3-methylglutaryl CoA (HMG-CoA reductase) reductase. ʻAʻole wale ia he hopena ikaika i ka hōʻemi ʻana i ka LDL-C a me TC, akā he polymorphism genetic koʻikoʻi hoʻi, bioavailability kiʻekiʻe, a me ka hapalua ola lōʻihi. A he kakaikahi wale nō ka poʻe e hana ana i ka metabolism CYP2C9. Hoʻohana ʻia e mālama i ka hyperlipidemia mua, ka hypercholesterolemia familial, a me nā maʻi lipid i hui pū ʻia.

Laʻana Huahana

Hoʻopili Huahana:

ʻIke Hou Aʻe:

Hoʻonohonoho ʻana	C25H24FNO4
Hoʻāʻo	99%
helehelena	Pauka keʻokeʻo a keʻokeʻo ʻole
Helu CAS.	147511-69-1
Hoʻopili ʻana	25KG
Ola Papa	2 mau makahiki
Ka Waihona	E mālama i kahi maloʻo a me kahi anuanu
Palapala hōʻoia	ISO.